BPLPHARMA vs FABTECH: Stock Comparison

BHARAT PARENTERALS vs FABTECH TECHNOLOGIESUpdated 17 Sept 26, 12:09 PM ISTNSE & company filings

BHARAT PARENTERALS shows a lower P/E, while FABTECH TECHNOLOGIES shows a higher dividend yield, faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BPLPHARMA leads 2; FABTECH leads 7 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BPLPHARMAFABTECH

Valuation lens

What price are you paying?

Market CapContext only
₹0 Cr
₹654 Cr
P/E RatioBPLPHARMA has the lower reading
0x
13.38x
P/B RatioFABTECH has the lower reading
3.18x
1.55x
EPSFABTECH has the higher reading
₹5.31
₹10.96
Book ValueContext only
₹452.09
₹109.44
Dividend YieldFABTECH has the higher reading
0.13%
0.41%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
BPLPHARMA has a lower P/E
0x vs 13.38x
P/B Ratio
FABTECH has a lower P/B
1.55x vs 3.18x
EPS
FABTECH has higher earnings per share
₹10.96 vs ₹5.31
Dividend Yield
FABTECH has a higher dividend yield
0.41% vs 0.13%
Revenue Growth (TTM YoY)
FABTECH has faster revenue growth
17.5% vs 0%
EPS Growth (TTM YoY)
FABTECH has faster EPS growth
23.4% vs 0%
Qtr Sales Growth
FABTECH has stronger quarterly sales growth
-34.46% vs -40.79%
Qtr Profit Growth
BPLPHARMA has stronger quarterly profit growth
202.63% vs -74.83%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBPLPHARMAFABTECH
SectorHealthcare
IndustryMedical Equipment & Supplies

Price

MetricBPLPHARMAFABTECH
Live Price₹1,547₹147.34
Day Change2.46%1.15%
Volume2330,582
52-Week High₹1,649₹262.8
52-Week Low₹1,125.7₹132.7
Distance from 52W High-6.19%-43.93%

Valuation

MetricBPLPHARMAFABTECH
Market Cap₹0 Cr₹654 Cr
P/E Ratio0x13.38x
P/B Ratio3.18x1.55x
EPS₹5.31₹10.96
Book Value₹452.09₹109.44
Dividend Yield0.13%0.41%

Growth

MetricBPLPHARMAFABTECH
Revenue Growth (TTM YoY)0%17.5%
EPS Growth (TTM YoY)0%23.4%
Qtr Sales Growth-40.79%-34.46%
Qtr Profit Growth202.63%-74.83%

Profitability & Leverage

MetricBPLPHARMAFABTECH
ROE6.22%
ROCE6.94%
Net Margin0%11.28%
Operating Margin13.72%
Debt to Equity0.05x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBPLPHARMAFABTECH
Promoter Holding67.2% 0.03 pp68.94%
FII Holding0.11%0.02% 0.06 pp
DII Holding1.37% 0.31 pp2.45% 0.3 pp
Public Holding31.31% 0.35 pp28.58% 0.25 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BHARAT PARENTERALS and FABTECH TECHNOLOGIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.